|
7. KANNALIFE SCIENCES INVESTMENT (Details Narrative) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Net income (loss) from Kannalife | $ (38,552)us-gaap_IncomeLossFromEquityMethodInvestments | $ (310,754)us-gaap_IncomeLossFromEquityMethodInvestments |
| Kannalife Sciences | ||
| Net income (loss) from Kannalife |
(38,552)us-gaap_IncomeLossFromEquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = canv_KannalifeSciencesMember |
(310,754)us-gaap_IncomeLossFromEquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = canv_KannalifeSciencesMember |
| Gain on sale of equity investments |
$ 7,899,306us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = canv_KannalifeSciencesMember |
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) on sale or disposal of an equity method investment. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|